Advertisement
top banner image  

topleft corner image     top right corner image
 
ACCF/AHA Clinical Guidelines and Statements

CME logo image
bullet
bullet
bullet
bullet

JACC Homepage JACC Imaging Homepage
Still not a subscriber to JACC Imaging or JACC Interventions?

take action
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

acc links
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet
bullet

jacc interventions image
bullet
bullet
bullet
bullet

     top nav image

     

J Am Coll Cardiol Intv, 2008; 1:552-560, doi:10.1016/j.jcin.2008.07.004
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sorajja, P.
Right arrow Articles by Holmes, D. R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Sorajja, P.
Right arrow Articles by Holmes, D. R., Jr

Clinical Research

Effect of Septal Ablation on Myocardial Relaxation and Left Atrial Pressure in Hypertrophic Cardiomyopathy

An Invasive Hemodynamic Study

Paul Sorajja, MD, Rick A. Nishimura, MD*, Steve R. Ommen, MD, Charanjit S. Rihal, MD, Bernard J. Gersh, MB, ChB, DPhil, David R. Holmes, Jr, MD

Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota

* Reprint requests and correspondence: Dr. Rick A. Nishimura, 200 1st Street SW, Rochester, Minnesota 55906 (Email: rick.nishimura{at}mayo.edu).

Objectives: The objective of this study was to examine the effects of septal ablation on diastolic function with the use of invasive hemodynamics.

Background: Septal ablation is an alternative therapy for patients with obstructive hypertrophic cardiomyopathy (HCM). However, its beneficial effect on diastolic function, by relieving the systolic contraction load, may be countered by adverse effects from the infarction on left ventricular mechanics.

Methods: Using high-fidelity, micromanometer-tipped catheters, we examined 40 HCM patients by taking direct measurements of the left ventricular outflow tract (LVOT) gradient, time constant of myocardial relaxation (tau), and left atrial pressure (LAP) before and after septal ablation.

Results: Although there was an overall reduction in LVOT gradient, septal ablation resulted in variable changes in myocardial relaxation and left atrial pressure. In 20 patients (50%), LAP increased. The magnitude of LVOT gradient reduction directly correlated with the effects of septal ablation on LAP (R = 0.58; p < 0.0001). Those patients with a greater decrease in the LVOT gradient had better improvement in direct LAP. Furthermore, those patients with a larger decrease in left ventricular outflow tract gradient had a beneficial enhancement of ventricular relaxation, as measured by tau (R = 0.43; p = 0.006). Thus, the beneficial enhancement of relaxation was directly related to improvement in LAP (R = 0.75; p < 0.0001).

Conclusions: Septal ablation results in variable effects on left ventricular filling pressure, which are dependent upon the magnitude of reduction in the LVOT gradient. These effects are mediated in part by effects of ablation on myocardial relaxation. These findings shed insight into the pathophysiologic effects of septal reduction therapy in patients with HCM.

Key Words: hypertrophic cardiomyopathy • septal ablation • diastole

Abbreviations and Acronyms
  EDP = end-diastolic pressure
  HCM = hypertrophic cardiomyopathy
  LAP = left atrial pressure
  LV = left ventricle
  LVOT = left ventricular outflow tract
  tau = time constant of myocardial relaxation




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
B. J. Gersh, B. J. Maron, R. O. Bonow, J. A. Dearani, M. A. Fifer, M. S. Link, S. S. Naidu, R. A. Nishimura, S. R. Ommen, H. Rakowski, et al.
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons
J. Am. Coll. Cardiol., December 13, 2011; 58(25): e212 - e260.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. V. Sherrid, O. Wever-Pinzon, A. Shah, and F. A. Chaudhry
Reflections of Inflections in Hypertrophic Cardiomyopathy
J. Am. Coll. Cardiol., July 14, 2009; 54(3): 212 - 219.
[Abstract] [Full Text] [PDF]



Advertisement
 
   
 
home link current link search link archive link topics link cardiology careers link